An Australia and New Zealand-wide survey of extracorporeal membrane oxygen (ECMO)-related infection and dressing and securement practices.

Not Applicable

Completed

• Conditions: Extracorporeal membrane oxygenation; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12618001109291
• Lead Sponsor: The Prince Charles Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-04
• Study Completion: 2018-11-27
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 127

Inclusion Criteria

(1) Patients undergoing ECMO treatment with a circuit that includes a membrane oxygenator and pump
(2) Patients decannulated from ECMO <48 hours prior to data collection days

Exclusion Criteria

(1) Patients who have already had data captured on a previous data collection day
(2) Patients decannulated from ECMO for > 48 hours on data collection days
(3) ECMO circuit does not include a membrane oxygenator and pump

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of ECMO cannulation site infection (localised infection) as per hospital medical and pathology records.[From commencement of ECMO therapy until point prevalence day];Prevalence of ECMO cannula-related blood stream infection as per hospital medical and pathology records.[From commencement of ECMO therapy until point prevalence day];Prevalence of any other hospital-acquired infection as per hospital medical and pathology records.[On point prevalence data collection day]

Secondary Outcome Measures

Name	Time	Method
ECMO cannula dressing and securement practices as documented in medical records.[On point prevalence data collection days];Adherence to that ECMO centre's cannula dressing and securement guidelines as per medical records.[On point prevalence data collection days.]